This is why retail investors should not be speculating in biotech: so if 2-73 fails despite all the "signals" we erroneously believed Missling was "sending" us, he is at fault.
He's not The Good Doctor. He's not sending signals. He's not trying to burn shorts. He's not our sugar daddy. He's a bright, hard-working guy running a young biotech that's trying to develop a drug therapy for an extremely complicated and puzzling disease, whose stock is available for public investment.
There's no crying in baseball, or investing.
News 
Market Data 
Discover 
AI
